###begin article-title 0
Post Genome-Wide Association Studies of Novel Genes Associated with Type 2 Diabetes Show Gene-Gene Interaction and High Predictive Value
###end article-title 0
###begin p 1
Conceived and designed the experiments: PF DM MP BB IB BG RS SCzernichow SH GC SCauchi WP MC MM JW AV. Performed the experiments: ED HC JD. Analyzed the data: SCauchi CP. Contributed reagents/materials/analysis tools: FD SG FA. Wrote the paper: SCauchi .
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Recently, several Genome Wide Association (GWA) studies in populations of European descent have identified and validated novel single nucleotide polymorphisms (SNPs), highly associated with type 2 diabetes (T2D). Our aims were to validate these markers in other European and non-European populations, then to assess their combined effect in a large French study comparing T2D and normal glucose tolerant (NGT) individuals.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 136 142 136 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 146 155 146 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7756992</sub>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 185 187 185 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 190 199 190 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 203 213 203 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10811661</sub>
###xml 233 234 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 243 245 243 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 269 275 269 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 279 288 279 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs1470579</sub>
###xml 308 309 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 463 469 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 596 602 596 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 607 612 607 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 646 654 646 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC38776</italic>
###xml 656 663 656 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 676 680 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGN3</italic>
###xml 682 691 682 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 906 912 906 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
In the same French population analyzed in our previous GWA study (3,295 T2D and 3,595 NGT), strong associations with T2D were found for CDKAL1 (ORrs7756992 = 1.30[1.19-1.42], P = 2.3x10-9), CDKN2A/2B (ORrs10811661 = 0.74[0.66-0.82], P = 3.5x10-8) and more modestly for IGFBP2 (ORrs1470579 = 1.17[1.07-1.27], P = 0.0003) SNPs. These results were replicated in both Israeli Ashkenazi (577 T2D and 552 NGT) and Austrian (504 T2D and 753 NGT) populations (except for CDKAL1) but not in the Moroccan population (521 T2D and 423 NGT). In the overall group of French subjects (4,232 T2D and 4,595 NGT), IGFBP2 and CXCR4 synergistically interacted with (LOC38776, SLC30A8, HHEX) and (NGN3, CDKN2A/2B), respectively, encoding for proteins presumably regulating pancreatic endocrine cell development and function. The T2D risk increased strongly when risk alleles, including the previously discovered T2D-associated TCF7L2 rs7903146 SNP, were combined (8.68-fold for the 14% of French individuals carrying 18 to 30 risk alleles with an allelic OR of 1.24). With an area under the ROC curve of 0.86, only 15 novel loci were necessary to discriminate French individuals susceptible to develop T2D.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 15 30 15 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2, SLC30A8</italic>
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 86 100 86 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1, IGFBP2</italic>
###xml 105 114 105 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
In addition to TCF7L2, SLC30A8 and HHEX, initially identified by the French GWA scan, CDKAL1, IGFBP2 and CDKN2A/2B strongly associate with T2D in French individuals, and mostly in populations of Central European descent but not in Moroccan subjects. Genes expressed in the pancreas interact together and their combined effect dramatically increases the risk for T2D, opening avenues for the development of genetic prediction tests.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 161 164 161 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Sladek1">[1]</xref>
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Steinthorsdottir1">[5]</xref>
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 329 336 329 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 344 353 344 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 362 365 362 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Sladek1">[1]</xref>
###xml 470 476 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 478 487 478 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 492 498 492 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 534 540 534 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 542 549 542 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 554 558 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 558 561 558 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Scott1">[2]</xref>
###xml 562 565 562 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Steinthorsdottir1">[5]</xref>
###xml 595 600 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP26</italic>
###xml 602 606 602 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LDLR</italic>
###xml 608 614 608 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCTD12</italic>
###xml 616 622 616 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CAMTA1</italic>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGN3</italic>
###xml 630 635 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 637 646 637 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC646279</italic>
###xml 759 762 759 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Sladek1">[1]</xref>
###xml 851 854 851 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Scott1">[2]</xref>
###xml 855 858 855 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Steinthorsdottir1">[5]</xref>
Recently, genome-wide association (GWA) studies have revealed new single nucleotide polymorphisms (SNPs) that are strongly associated with type 2 diabetes (T2D) [1]-[5]. In our French study, we showed that the well known rs7903146 TCF7L2 polymorphism ranked first for its effect on T2D prevalence followed by four new risk loci: SLC30A8, HHEX, LOC387761 and EXT2[1]. Subsequently, GWA studies in Finnish, English, Icelandic and Danish populations emphasized the role of CDKAL1, CDKN2A/2B and IGFBP2 on T2D and confirmed the effect of TCF7L2, SLC30A8 and HHEX[2]-[5]. Additional SNPs, located in MMP26, LDLR, KCTD12, CAMTA1, NGN3, CXCR4, LOC646279, were also among the 15 first signals in the joint stage I and fast track stage II analyses of the French study [1], but their current status is uncertain as they did not rank high in the other GWA scans [2]-[5]. Although the other loci listed above are likely to be true T2D markers, the actual impact of these genetic variants in other European and non-European populations as well as their cumulative effects and potential interactions remain to be determined.
###end p 9
###begin p 10
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 71 80 71 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 85 91 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 254 257 254 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Sladek1">[1]</xref>
In the present study, we first investigated the association of CDKAL1, CDKN2A/2B and IGFBP2 SNPs with T2D in the French population that we analyzed in our GWA study followed by a fast track replication [3,295 T2D and 3,595 normal glucose tolerant (NGT)] [1]. Then, 22 SNPs in 14 loci previously associated with T2D in GWA studies were selected and analyzed in four additional independent populations of European [French (937 T2D and 1,000 NGT), Austrian (504 T2D and 753 NGT), Israeli Ashkenazi (577 T2D and 552 NGT)] and Moroccan Arabic (521 T2D and 423 NGT) origin. Finally, in the overall group of French individuals (4,232 T2D and 4,595 NGT), we assessed possible gene-gene interactions and determined the cumulative genetic risk of carrying risk alleles on T2D prevalence.
###end p 10
###begin title 11
Results
###end title 11
###begin p 12
###xml 60 68 60 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002031.s002">Table S1</xref>
###xml 276 284 276 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002031.s003">Table S2</xref>
Clinical characteristics of each population are reported in Table S1. Minimum detectable effect size with a statistical power of 80% was calculated for each SNP in all studied samples and linkage disequilibrium was assessed between genetic variants located in the same locus (Table S2).
###end p 12
###begin title 13
Association studies in our original set of French individuals
###end title 13
###begin p 14
###xml 204 210 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 212 221 212 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 226 232 226 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 265 274 265 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7756992</sub>
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 305 307 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 311 321 311 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10811661</sub>
###xml 342 343 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 352 354 352 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 362 371 362 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs1470579</sub>
###xml 392 393 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 420 427 420 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002031-t001">Table 1</xref>
###xml 497 498 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 498 501 498 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
We first studied whether 3 risk loci (7 SNPs) identified in Finnish, English, and Icelandic-Danish populations conferred risk in our original French population (3,295 T2D and 3,595 NGT). Polymorphisms of CDKAL1, CDKN2A/2B and IGFBP2 were all associated with T2D (ORrs7756992 = 1.30 [1.19-1.42], P = 2.3x10-9; ORrs10811661 = 0.74 [0.66-0.82], P = 3.5x10-8; and ORrs1470579 = 1.17 [1.07-1.27], P = 0.0003), respectively) (Table 1). In this population and for each SNP, the best mode of inheritance (Pmax) was found to be multiplicative.
###end p 14
###begin title 15
Genotypic distribution by number of individuals (%) of the 7 SNPs studied in the first set of French population
###end title 15
###begin p 16
Odds ratios were adjusted for age, gender and BMI under a multiplicative model
###end p 16
###begin p 17
NGT: Normal Glucose Tolerant
###end p 17
###begin p 18
T2D: Type 2 Diabetic
###end p 18
###begin p 19
Allele 1: Major allele
###end p 19
###begin p 20
Allele 2: Minor allele (tested)
###end p 20
###begin title 21
Replication studies in 4 additional independent populations
###end title 21
###begin p 22
###xml 262 265 262 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Sladek1">[1]</xref>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCTD12</italic>
###xml 409 415 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 417 426 417 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 428 434 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 445 449 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 568 571 568 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Scott1">[2]</xref>
###xml 572 575 572 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Steinthorsdottir1">[5]</xref>
The 22 SNPs located in the 14 loci that we identified in our previous study were analyzed in other independent populations. For each polymorphism, the best fitting genetic model was selected from our previous whole-genome association study in French individuals [1]. Thus, all polymorphisms were analyzed under a multiplicative genetic model except for EXT2 (dominant model) and KCTD12 (recessive model). For CDKAL1, CDKN2A/2B, IGFBP2, HHEX and EXT2, we studied more than one polymorphism because they have all been reported as associated with T2D in previous studies [2]-[5].
###end p 22
###begin p 23
###xml 103 110 103 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002031-t002">Table 2</xref>
###xml 147 156 147 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC646279</italic>
###xml 160 169 160 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs1256517</sub>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#8202;=&#8202;</italic>
###xml 200 209 200 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
###xml 213 222 213 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7480010</sub>
###xml 243 247 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#8202;=&#8202;</italic>
###xml 254 261 254 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 265 275 265 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs13266634</sub>
###xml 296 297 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP26</italic>
###xml 316 325 316 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs2499953</sub>
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 360 365 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 369 380 369 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs932206&#8202;=&#8202;</sub>
###xml 398 399 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 529 533 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 537 546 537 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3740878</sub>
###xml 567 568 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 581 585 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 589 601 589 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs1111875&#8202;=&#8202;</sub>
###xml 619 620 619 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
We first analyzed another independent French group of more modest sample size (937 T2D and 1,000 NGT) (Table 2). Polymorphisms of predicted genes (LOC646279, ORrs1256517 = 1.44 [1.03-2.02], P = 0.03; LOC387761, ORrs7480010 = 1.32 [1.01-1.72], P = 0.04), SLC30A8 (ORrs13266634 = 0.76 [0.59-0.97], P = 0.03), MMP26 (ORrs2499953 = 2.45 [1.19-5.04], P = 0.01) and CXCR4 (ORrs932206 = 0.75 [0.57-0.97], P = 0.03) were more prevalent in T2D subjects than in NGT individuals. A trend towards T2D association was detected for one SNP of EXT2 (ORrs3740878 = 0.50 [0.23-1.07], P = 0.07) and HHEX (ORrs1111875 = 0.79 [0.60-1.02], P = 0.07).
###end p 23
###begin title 24
Genotypic distribution by number of individuals (%) of the 22 SNPs studied in the second set of French population
###end title 24
###begin p 25
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCTD12</italic>
Odds ratios were adjusted for age, gender and BMI under a multiplicative model except for EXT2 (dominant) and KCTD12 (recessive)
###end p 25
###begin p 26
NGT: Normal Glucose Tolerant
###end p 26
###begin p 27
T2D: Type 2 Diabetic
###end p 27
###begin p 28
Allele 1: Major allele
###end p 28
###begin p 29
Allele 2: Minor allele (tested)
###end p 29
###begin p 30
: Dominant genetic model
###end p 30
###begin p 31
: Recessive genetic model
###end p 31
###begin p 32
###xml 70 77 70 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002031-t003">Table 3</xref>
###xml 109 118 109 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 122 135 122 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10811661&#8202;=&#8202;</sub>
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 175 187 175 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs4402960&#8202;=&#8202;</sub>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 216 223 216 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 227 240 227 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs13266634&#8202;=&#8202;</sub>
###xml 258 259 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGN3</italic>
###xml 280 292 280 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7923837&#8202;=&#8202;</sub>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Then, the same SNPs were analyzed in Austrians (504 T2D and 753 NGT) (Table 3). Associations between SNPs of CDKN2A/2B (ORrs10811661 = 0.67 [0.52-0.87], P = 0.002), IGFBP2 (ORrs4402960 = 1.25 [1.02-1.53], P = 0.03), SLC30A8 (ORrs13266634 = 0.76 [0.61-0.94], P = 0.01) and NGN3 (ORrs7923837 = 0.73 [0.59-0.91], P = 0.005) loci and T2D were identified.
###end p 32
###begin title 33
Genotypic distribution by number of individuals (%) for the 22 SNPs studied in the Austrian population
###end title 33
###begin p 34
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCTD12</italic>
Odds ratios were adjusted for age, gender and BMI under a multiplicative model except for EXT2 (dominant) and KCTD12 (recessive)
###end p 34
###begin p 35
NGT: Normal Glucose Tolerant
###end p 35
###begin p 36
T2D: Type 2 Diabetic
###end p 36
###begin p 37
Allele 1: Major allele
###end p 37
###begin p 38
Allele 2: Minor allele (tested)
###end p 38
###begin p 39
: Dominant genetic model
###end p 39
###begin p 40
: Recessive genetic model
###end p 40
###begin p 41
###xml 53 62 53 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 66 77 66 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs564398&#8202;=&#8202;</sub>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 116 128 116 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7754840&#8202;=&#8202;</sub>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 159 171 159 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7756992&#8202;=&#8202;</sub>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 200 206 200 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 210 222 210 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs1470579&#8202;=&#8202;</sub>
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 263 274 263 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs729287&#8202;=&#8202;</sub>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 364 371 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002031-t004">Table 4</xref>
In Israeli Ashkenazi subjects (577 T2D and 552 NGT), CDKN2A/2B (ORrs564398 = 1.26 [1.03-1.53], P = 0.02), CDKAL1 (ORrs7754840 = 1.30 [1.08-1.56], P = 0.005; ORrs7756992 = 1.24 [1.03-1.49], P = 0.02), IGFBP2 (ORrs1470579 = 1.34 [1.12-1.61], P = 0.001) and EXT2 (ORrs729287 = 0.43 [0.21-0.88], P = 0.02) were more prevalent in the T2D group than in NGT individuals (Table 4).
###end p 41
###begin title 42
Genotypic distribution by number of individuals (%) of the 22 SNPs studied in the Israeli Ashkenazi population
###end title 42
###begin p 43
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCTD12</italic>
Odds ratios were adjusted for age, gender and BMI under a multiplicative model except for EXT2 (dominant) and KCTD12 (recessive)
###end p 43
###begin p 44
NGT: Normal Glucose Tolerant
###end p 44
###begin p 45
T2D: Type 2 Diabetic
###end p 45
###begin p 46
Allele 1: Major allele
###end p 46
###begin p 47
Allele 2: Minor allele (tested)
###end p 47
###begin p 48
: Dominant genetic model
###end p 48
###begin p 49
: Recessive genetic model
###end p 49
###begin p 50
###xml 145 151 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 155 167 155 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7754840&#8202;=&#8202;</sub>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 197 207 197 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs10946398</sub>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 242 251 242 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC646279</italic>
###xml 255 267 255 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs1256517&#8202;=&#8202;</sub>
###xml 285 286 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 296 303 296 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002031-t005">Table 5</xref>
Finally, we also investigated a population of Moroccan origin (521 T2D and 423 NGT), in which only trends for association were found for SNPs of CDKAL1 (ORrs7754840 = 1.20 [0.99-1.46], P = 0.06; ORrs10946398 = 1.21 [0.99-1.47], P = 0.06) and LOC646279 (ORrs1256517 = 0.84 [0.69-1.02], P = 0.07) (Table 5).
###end p 50
###begin title 51
Genotypic distribution by number of individuals (%) of the 22 SNPs studied in the Morrocan population
###end title 51
###begin p 52
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCTD12</italic>
Odds ratios were adjusted for age, gender and BMI under a multiplicative model except for EXT2 (dominant) and KCTD12 (recessive)
###end p 52
###begin p 53
NGT: Normal Glucose Tolerant
###end p 53
###begin p 54
T2D: Type 2 Diabetic
###end p 54
###begin p 55
Allele 1: Major allele
###end p 55
###begin p 56
Allele 2: Minor allele (tested)
###end p 56
###begin p 57
: Dominant genetic model
###end p 57
###begin p 58
: Recessive genetic model
###end p 58
###begin title 59
Gene-gene interactions and cumulative genetic effects in French subjects
###end title 59
###begin p 60
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 321 324 321 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Weedon1">[6]</xref>
For each studied locus, we selected the most T2D-associated SNP, including TCF7L2 rs7903146 (N = 15) in order to assess their cumulative effects on T2D prevalence as well as potential gene-gene interactions (i.e., deviation from a multiplicative model) in the complete set of French individuals (4,232 T2D and 4,595 NGT) [6].
###end p 60
###begin p 61
###xml 66 75 66 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002031.s001">Figure S1</xref>
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 125 134 125 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 157 164 157 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 208 209 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 258 264 258 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 318 319 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 373 378 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGN3</italic>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 424 433 424 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All pairwise combinations (N = 253) were studied for the 15 SNPs (Figure S1). We found interactions of IGFBP2 rs1470579 with LOC387761 rs7480010 (P = 0.04), SLC30A8 rs13266634 (P = 0.007) and HHEX rs7923837 (P = 0.01). Similarly, we detected interactions of IGFBP2 rs4402960 with the same loci (P = 0.02, P = 0.01 and P = 0.008, respectively). Furthermore, interactions of CXCR4 rs932206 with NGN3 rs10823406 (P = 0.02) and CDKN2A/2B rs10811661 (P = 0.02) were also found. No antagonistic effects were detected.
###end p 61
###begin p 62
###xml 120 128 120 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002031-g001">Figure 1</xref>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCTD12</italic>
###xml 339 347 339 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002031-g002">Figure 2</xref>
The percentages of individuals with increasing numbers of risk alleles in T2D subjects and NGT individuals are shown in Figure 1. For all SNPs, including those of EXT2 and KCTD12, we considered their multiplicative allelic effects on T2D prevalence. The ORs for T2D in subjects carrying increasing numbers of risk alleles are presented in Figure 2 in comparison to the 7.5% of the study population in the reference group that have 0 to 10 risk alleles. After adjustment for age, body mass index (BMI) and gender, each additional risk allele increased the odds of disease by 1.24 [1.21-1.27]. Individuals with at least 18 risk alleles (6.1% of NGT individuals and 14.5% of T2D subjects) had an OR of 8.68 [6.37-11.83] compared to the reference group.
###end p 62
###begin title 63
Percentage distribution of NGT and T2D individuals by number of risk alleles.
###end title 63
###begin title 64
Odds ratios for French individuals carrying increasing numbers of risk alleles.
###end title 64
###begin p 65
###xml 423 424 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 431 434 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;71</sup>
Fifteen T2D genetic variants identified by GWA studies were analyzed in 4,232 T2D and 4,595 NGT French subjects for their cumulative effects on T2D prevalence. Allelic ORs and 95%-CIs were calculated using logistic regression model adjusted for age, gender and BMI. They are presented for each group, defined by their number of T2D risk alleles. Each additional allele increases in average the risk to develop T2D by 24 % (P = 8x10-71).
###end p 65
###begin p 66
###xml 85 88 85 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Janssens1">[7]</xref>
###xml 307 315 307 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002031-g003">Figure 3</xref>
The predictive power of tests can be evaluated by the area under the ROC curve (AUC) [7]. The AUC is a measure of the discriminatory power of the test. A perfect test would have an AUC of 1; a test with no discriminatory power, an AUC of 0.5. For the 15 polymorphisms, the area under the ROC curve is 0.86 (Figure 3), corresponding to a high predictive power.
###end p 66
###begin title 67
ROC for the information provided by the 15 T2D-associated genetic variants.
###end title 67
###begin p 68
We used a logistic regression model adjusted for age, gender and BMI including a covariate for the number of risk alleles. The area under the ROC curve was 0.86. Academic point system: 0.90-1 = excellent; 0.80-0.90 = good; 0.70-0.80 = fair; 0.60-0.70 = poor; 0.50-0.60 = fail.
###end p 68
###begin title 69
Discussion
###end title 69
###begin p 70
###xml 23 26 23 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Sladek1">[1]</xref>
###xml 27 30 27 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Steinthorsdottir1">[5]</xref>
###xml 53 56 53 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Hayes1">[8]</xref>
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Florez1">[11]</xref>
GWA scans in Europeans [1]-[5] and other populations [8]-[11] have recently identified and confirmed new genetic variants associated with T2D. However, the clinical interest of these discoveries will depend on their true contribution in other ethnic groups as well as on their predictive value for T2D risk.
###end p 70
###begin p 71
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CKN2A/2B</italic>
###xml 152 158 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 209 212 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Scott1">[2]</xref>
###xml 213 216 213 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Steinthorsdottir1">[5]</xref>
###xml 747 750 747 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Scott1">[2]</xref>
###xml 800 807 800 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 809 814 809 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP26</italic>
###xml 816 821 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 823 832 823 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC387761</italic>
###xml 837 846 837 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC646279</italic>
Using the same study design as our French GWA scan (joint stage I and fast track stage II), we confirmed the strong association of CDKAL1, CKN2A/2B and IGFBP2 SNPs with T2D previously found by other GWA scans [2]-[5]. Intriguingly, these results were not replicated in another independent French population. This may be due to the modest sample size and/or because T2D cases and NGT controls were not specifically selected from families with or without history of diabetes, respectively, and/or because T2D cases and NGT controls were not matched for BMI. Our data show that the level of association of some SNPs with T2D depends on factors other than just ethnicity. Similar discordant results were also found among European cohorts from Finland [2]. However, we replicated our previous results for SLC30A8, MMP26, CXCR4, LOC387761 and LOC646279 SNPs, suggesting that these loci may be truly involved in T2D risk in the French population.
###end p 71
###begin p 72
###xml 106 115 106 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 125 132 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 138 142 138 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGN3</italic>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EXT2</italic>
###xml 369 375 369 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 377 386 377 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 391 397 391 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 468 474 468 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Cauchi1">[12]</xref>
In another mid-sized population from Central Europe (Austria), associations with T2D were found only with CDKN2A/2B, IGFBP2, SLC30A8, and NGN3 SNPs supporting the value of using large homogeneous populations to characterize the T2D genetic architecture in a given population. In Israeli Ashkenazi individuals, in whom one EXT2 SNP was found to be a T2D genetic marker, CDKAL1, CDKN2A/2B and IGFBP2 SNPs were associated with T2D, as in French subjects. Even though the TCF7L2 rs790146 SNP was previously associated with T2D in this Moroccan group [12], no association was detected with any of the newly studied SNPs. While this lack of association may be due to the modest sample size or hidden biases such as population stratification, it may also signify that other SNPs in the same genes or located in different genes could be associated in the North African population.
###end p 72
###begin p 73
###xml 35 44 35 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 150 157 150 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002031-t006">Table 6</xref>
###xml 258 264 258 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Schulze1">[13]</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Omori1">[17]</xref>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Helgason1">[18]</xref>
Among the 14 studied loci, only 3 (CDKN2A/2B, IGFBP2 and SLC30A8) were found to be associated with T2D in at least 3 independent case-control groups (Table 6). Their association was recently confirmed in other subjects of European or Japanese origin, as for CDKAL1 and HHEX[13]-[17]. For the other loci, further meta-analyses and systematic replications of GWA studies (phase 2) are now necessary to fully evaluate their contribution to T2D risk. In the light of discrepancies between studied populations, GWA scans in non-European ethnic groups may bring additional insight. Further efforts in re-sequencing [18] are also needed to find etiologic variants causing T2D.
###end p 73
###begin title 74
Summary of replication results in the 5 case-control groups
###end title 74
###begin p 75
+: At least one SNP detected associated with T2D
###end p 75
###begin p 76
-: No SNP detected associated with T2D
###end p 76
###begin p 77
( ) : Previously known data
###end p 77
###begin p 78
###xml 226 232 226 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 260 268 260 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LOC38776</italic>
###xml 270 277 270 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HHEX</italic>
###xml 516 519 516 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Zeggini1">[3]</xref>
###xml 548 555 548 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8</italic>
###xml 674 678 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Chimienti1">[19]</xref>
###xml 680 684 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Chimienti2">[20]</xref>
###xml 701 706 701 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 747 751 747 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGN3</italic>
###xml 756 765 756 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 885 889 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NGN3</italic>
###xml 889 893 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Koblas1">[21]</xref>
###xml 895 901 895 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A</italic>
###xml 951 955 951 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Frayling1">[22]</xref>
###xml 1031 1035 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Krishnamurthy1">[23]</xref>
There is a growing interest in analyzing the combined effect of these novel loci on T2D susceptibility. This is the first time, to our knowledge, that potential synergistic interactions between novel T2D loci have been shown. IGFBP2 SNPs seem to interact with LOC38776, SLC30A8 and HHEX genetic variants. These data are in agreement with a primary beta-cell dysfunction. IGF2BP2 binds to the key growth and insulin signaling molecule insulin-like growth factor 2 (IGFII) and is highly expressed in pancreatic islets [3]. The zinc transporter ZnT8 (SLC30A8 protein) is specifically expressed in pancreatic endocrine cells and may participate in regulating insulin exocytosis [19], [20]. Similarly, the CXCR4 risk variant was found to interact with NGN3 and CDKN2A/2B SNPs. It was reported that CXCR4-positive pancreatic cells express markers of pancreatic endocrine progenitors such as NGN3[21]. CDKN2A could be a possible biological candidate for T2D [22] as its over-expression in rodents causes a decrease in islet proliferation [23]. The emerging picture of these possible interactions emphasizes the ability of multiple SNPs to potentiate their deleterious effects in both beta-cell development and function.
###end p 78
###begin p 79
###xml 226 232 226 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPARG</italic>
###xml 244 250 244 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 369 372 369 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Weedon1">[6]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Yang1">[24]</xref>
###xml 993 997 993 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Mokdad1">[25]</xref>
The evaluation of the T2D risk in individuals carrying increasing numbers of risk variants is critical for a potential clinical use of a genetic test in the general population. It was previously shown that UK individuals with TCF7L2, PPARG and KCNJ11 risk alleles had an OR of 5.71-fold (95% CI, 1.15 to 28.3) compared to those with no risk alleles, for an AUC of 0.58 [6]. It has been suggested that 20-25 risk variants with allele frequencies greater than 0.1 and ORs of 1.5 are required for an AUC of about 0.8 [24]. In our study, with only 15 SNPs, we reached a good discriminating power to identify individuals with high susceptibility for T2D. After adjustments for age, BMI and gender, subjects with at least 18 risk alleles (14.5% of French T2D subjects) had approximately 9-fold higher risk of developing T2D compared to the reference group, for an AUC of 0.86. If confirmed, this increase in T2D risk due to genetic factors is even higher than that due to severe obesity (OR = 7.37) [25], the most established T2D risk factor.
###end p 79
###begin p 80
After many years of limited success, the genetic architecture of T2D (common SNPs) is finally being uncovered by GWA studies. Even though the absence or presence of association in a given population is dependent on many factors (e.g., number of individuals, ethnicity, SNP prevalence, BMI, familial history of T2D and others), replication studies certainly help in validating SNPs truly associated with T2D and in excluding false positives.
###end p 80
###begin p 81
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Yang2">[26]</xref>
Our data support the concept that T2D loci may interact together. Consequently, while single polygenic susceptibility variants may be of limited use in disease prediction, the combined information from a number of these variants should allow the identification of groups of subjects at high and low risk of developing a complex disease [26]. Hence, our study opens up the way to new applications in public health, based on early genetic testing for better prevention and care.
###end p 81
###begin title 82
Materials and Methods
###end title 82
###begin title 83
Study design
###end title 83
###begin p 84
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKAL1</italic>
###xml 58 67 58 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A/2B</italic>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP2</italic>
###xml 343 346 343 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Scott1">[2]</xref>
###xml 347 350 347 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Steinthorsdottir1">[5]</xref>
###xml 482 488 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 558 561 558 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Sladek1">[1]</xref>
###xml 563 638 563 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC30A8, HHEX, EXT2, LOC646279, MMP26, KCTD12, LDLR, CAMTA1, LOC38776, NGN3</italic>
###xml 643 648 643 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 1026 1032 1026 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
We first investigated the association with T2D of CDKAL1, CDKN2A/2B and IGFBP2 SNPs in the same French population analyzed in our previous GWA study (3,295 T2D and 3,595 NGT). These 3 loci were selected for their high degree of association with T2D in GWA studies and their ability to be replicated in different populations of European origin [2]-[5]. In addition to these 3 loci, the role of 11 additional loci for which we found the 15 highest SNP association signals (except for TCF7L2) in the joint stage I and fast track stage II of the French GWA scan [1] (SLC30A8, HHEX, EXT2, LOC646279, MMP26, KCTD12, LDLR, CAMTA1, LOC38776, NGN3 and CXCR4) was evaluated in 4 additional independent groups (2,539 T2D and 2,728 NGT) of European (French, Austrian and Israeli Ashkenazi) and non-European (Moroccan) origin. Finally, in all French subjects, we assessed the cumulative genetic risk of carrying the studied risk alleles on T2D prevalence and their possible interactions, including the previously discovered T2D-associated TCF7L2 rs7903146 SNP.
###end p 84
###begin title 85
Study populations
###end title 85
###begin p 86
###xml 79 87 79 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002031.s002">Table S1</xref>
###xml 170 173 170 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Sladek1">[1]</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Hercberg1">[27]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Hadjadj1">[28]</xref>
The main clinical characteristics of each studied population were presented in Table S1. The first French group of T2D subjects and NGT controls was previously described [1].The second set of French samples includes NGT individuals from the "Supplementation en Vitamines et Mineraux Antioxydants" (SU.VI.MAX) cohort [27] and T2D subjects from the "DIABete de type 2, NEPHROpathie et GENEtique" (DIAB2.NEPHRO.GENE) study [28].
###end p 86
###begin p 87
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Hercberg2">[29]</xref>
###xml 218 230 <span type="species:ncbi:9606">participants</span>
###xml 474 486 <span type="species:ncbi:9606">participants</span>
The SU.VI.MAX study was a French population-based prevention trial designed to evaluate the impact of a daily antioxidant supplementation at nutritional doses on the incidence of ischemic heart disease and cancer. All participants were recruited from throughout France between October 1994 and June 1995. [29]. The NGT controls were selected when having no hypoglycemic treatment and a fasting glucose <6.1 mmol/l. At baseline, a 35-mL venous blood sample was obtained from participants who had been fasting for 12 hr at the time of the visit. The samples were collected in vacutainer tubes that do not interfere with the concentration of trace elements (Becton Dickinson). After collection, blood was kept at +4degreesC in the dark until centrifugation. Centrifugation was realized at standard time, gravity, and temperature. The time elapsing between collection and aliquoting was recorded for all samples; it was less than 1 hr. Aliquots were stored at -20degreesC in the mobile units and field centers for, at the most, 7 days prior to shipment in dry ice to the reference laboratories and coordinating center.
###end p 87
###begin p 88
###xml 453 460 <span type="species:ncbi:9606">patient</span>
###xml 753 759 <span type="species:ncbi:9606">people</span>
The DIAB2.NEPHRO.GENE study was a French multi-center case-control study (15 diabetes and 5 nephrology centers from throughout France between 2001 and 2004) designed to assess the genetic determinants of diabetic nephropathy in type 2 diabetes. T2D was diagnosed on clinically determined absence of type 1 or secondary diabetes, in individuals of more than 40 years of age at onset and without insulin treatment within 2 years after disease onset. Each patient record was carefully checked by an adjudication committee to ascertain T2D status and diabetic complications. 21 ml of blood drawn on EDTA were used for DNA extraction using standard procedures (ethanol precipitation) and samples were stored at -80degreesc until use. The number of recruited people was 11 in December 2001 (first month of the study), 491 subjects in 2002, 514 in 2003, 593 in 2004, 897 in 2005 and 229 thereafter.
###end p 88
###begin p 89
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Cauchi1">[12]</xref>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Esterbauer1">[30]</xref>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Meyre1">[32]</xref>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
###xml 469 477 <span type="species:ncbi:9606">patients</span>
###xml 538 550 <span type="species:ncbi:9606">Participants</span>
###xml 1020 1023 <span type="species:ncbi:9606">men</span>
###xml 1028 1033 <span type="species:ncbi:9606">women</span>
The Austrian subjects were of Bavarian and Austrian German descent and came from the greater region of Salzburg, Austria. They were recruited between April 1999 and December 2002. Unrelated patients with type 2 diabetes were recruited from diabetes outpatient clinics of the Landeskliniken Salzburg and the Hospital Hallein (near Salzburg). The diagnosis of T2D was based on use of hypoglycemic agents or plasma glucose values >126 mg/dl (in absence of treatment). The patients were seen repeatedly and managed by the outpatient clinics. Participants in the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk (SAPHIR) [12], [30]-[32] who were not using hypoglycemic medications and had fasting plasma glucose levels <110 mg/dL served as NGTcontrols. SAPHIR was a population-based prospective study that investigated the involvement of factors contributing to the control of plasma lipid transport and carbohydrate metabolism in the progression of atherosclerotic vascular disease. Unrelated men and women subjects with an age range between 39 and 67 years who live in the greater Salzburg region and responded to invitations by their family or workplace physician or to announcement in the local press were included in the study. Average rates of recruitment were 10 controls/week and 3 T2D subjects/week. For all samples, whole blood was collected after an overnight fast in tubes containing 1.6 mg/ml EDTA. Plasma was separated <30 min after collection and used immediately for analysis. Aliquots were stored at -70degreesC. Aliquots of blood collected in EDTA were stored at -70degreesC. Genomic DNA was extracted from whole blood and stored at -20degreesC prior to analysis.
###end p 89
###begin p 90
###xml 395 403 <span type="species:ncbi:9606">patients</span>
###xml 601 609 <span type="species:ncbi:9606">patients</span>
###xml 920 928 <span type="species:ncbi:9606">patients</span>
All Israeli NGT/T2D subjects lived and were ascertained in Israel with the help of 15 major diabetes treatment centers throughout the country. They were of Ashkenazi Jewish origin, defined as having all 4 grandparents born in Northern or Eastern Europe. Subjects with known or suspected Sephardic Jewish or non-Jewish ancestry were excluded. Thus, only Jewish subjects were recruited and Jewish patients from the Mediterranean basin, the Persian Gulf region (Iraq, Iran), Yemen, Ethiopia and other areas that were populated with Jews before the major Roman exile of 70 C.E. were not included. The T2D patients were ascertained between 2002 and 2004 in 15 diabetes clinics throughout Israel by the "Israel Diabetes Research Group" and were defined according to WHO criteria (fasting glucose >140mg/dl on two or more occasions, or random glucose >200 mg/dl on two or more occasions). To avoid late-onset type 1 diabetics, patients who became insulin-dependent within 2 years of diagnosis were excluded. The average age at diagnosis was 47 years old. The NGT controls were defined as Ashkenazi (Northern and Eastern European ancestry) with no history of glucose intolerance or T2D and were purchased from the National Laboratory for the Genetics of Israeli Populations (). They denied ever having been diagnosed with elevated blood glucose level, T2D or glucose intolerance. Whole blood samples were obtained in vacuum tubes containing EDTA. The samples were stored at 4degreesC and transferred to the Endocrine Laboratory at the Hadassah Hospital, Jerusalem Israel within 72h of collection. DNA was extracted using the Puregene Genomic DNA extraction kit purchased from Gentra Systems, Minneapolis, MN, U.S.A. according to the manufacturer's recommendations. Concentrated DNA was stored at -80degreesC, diluted stocks were stored at -20degreesC and working solutions were stored at 4degreesC.
###end p 90
###begin p 91
###xml 448 456 <span type="species:ncbi:9606">Patients</span>
Moroccan subjects were recruited, between February and July 2006, by the Faculty of Medicine (Fes) within the framework of the Genetic project Diabetes Morocco (GenDiabM: approximately180 subjects by month) and were subjected to a standardized clinical examination at the Hassan II Hospital and in regional health centers. The NGT and T2D subjects were from two Moroccan regions: Fes-Tounate (central-North region) and Rabat-Sale (western region). Patients with T2D were recruited from a registry of associations for T2D and health centers when they had a family history of T2D in first degree relatives. The diagnosis of T2D was made according to the 1997 American Diabetes Association criteria or on being treated with medications for diabetes. The NGT controls were recruited from an unselected population undergoing a routine health check-up at the same health centers. All control individuals >/=40 years of age, not previously diagnosed for T2D, with no history of T2D in first-degree relatives, and with fasting plasma glucose <6.1 mmol/l. Blood and serum samples (9 ml) were collected from all individuals and were immediately stored in frozen conditions (serum at -20degreesC and blood at -80degreesC) until use. Genomic DNA was then extracted from whole blood and stored at -20degreesC.
###end p 91
###begin p 92
###xml 218 230 <span type="species:ncbi:9606">participants</span>
In all populations, the studied individuals were unrelated to each other (with no first-degree relatives). This genetic study was approved by local Ethical Committees and written informed consent was obtained from all participants.
###end p 92
###begin title 93
SNP genotyping
###end title 93
###begin p 94
###xml 315 323 315 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002031.s003">Table S2</xref>
###xml 367 379 <span type="species:ncbi:9606">participants</span>
All the polymorphisms were genotyped using an allelic discrimination assay-by-design TaqMan method on ABI 7900 (Applied Biosystems). All genotypic distributions were in Hardy-Weinberg equilibrium. The genotyping success rate was higher than 98% for each SNP. For each SNP, the genotyping error rate was reported in Table S2 and assessed by randomly re-genotyping 384 participants in each population.
###end p 94
###begin title 95
Statistical analysis
###end title 95
###begin p 96
###xml 93 101 93 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002031-t002">Tables 2</xref>
###xml 102 102 102 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002031-t003"/>
###xml 102 102 102 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002031-t004"/>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002031-t005">5</xref>
###xml 111 119 111 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002031.s003">Table S2</xref>
###xml 551 552 551 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1285 1289 1285 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002031-Sing1">[33]</xref>
###xml 2031 2032 2031 2032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Odds ratios were assessed by logistic regression models adjusted for age, BMI and gender. In Tables 2-5 and in Table S2, we tested the effect of the minor allele. In these tables, the risk allele is the minor allele if the OR is >1 and is the major allele if the OR is <1. The replication of an association with T2D was considered positive on the condition that the risk allele was not different from what was found in previous GWA studies. For each population, a simple Bonferroni correction (multiplication by the number of SNPs) was applied to the P values for multiple comparisons. After correction, no association remained significant, except for those found in our original French population. However, in the context of replication, it remains unlikely to detect an effect due to statistical fluctuation only. We explored the effect of multiple SNPs using a logistic regression model including a variable for the number of risk alleles in order to quantify the risk per supplementary allele for all the variants included in the model. OR corresponding to a given number of risk alleles compared to the reference group was also calculated. We evaluated the ability of this model to discriminate between NGT and T2D individuals with a Receiver Operating Characteristic (ROC) curve [33] using a logistic regression model adjusted for age, gender and BMI including a covariate for the number of risk alleles of the 15 studied variants. The Area Under the ROC Curve (AUC) was calculated as a measure of the discriminative power of the test. Gene-gene interactions (i.e., deviation from a multiplicative model) were tested by comparing a logistic regression model including only the main effects to another model including the main effects and an interaction term with a likelihood ratio test. We further explored the way two variants interact with interaction plots. We used Quanto () for power calculations. Pairwise linkage disequilibrium between genetic markers was assessed using the R "genetics" package (version 1.3.2). All P values are two-sided. SPSS (version 14.0.2) and R statistics (version 2.5.1) software were used for general statistical analysis.
###end p 96
###begin title 97
Supporting Information
###end title 97
###begin p 98
Significant gene-gene interactions between genetic variants and T2D. 1: Homozygous for the protective allele; 2: Heterozygous; 3: Homozygous for the risk allele. The minimum number of samples by genotype intersection and by status is presented thereafter. A: 48, B: 27, C: 43, D: 37, E: 41, F: 31, G: 42, H: 16.
###end p 98
###begin p 99
(0.24 MB TIF)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin p 101
Clinical characteristics of the studied populations.
###end p 101
###begin p 102
(0.04 MB DOC)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin p 104
Linkage disequilibrium and minimum detectable effect size with a statistical power of 80% for the 22 SNPs in the 5 case-control groups.
###end p 104
###begin p 105
(0.12 MB DOC)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin p 107
We are indebted to all subjects who participated to this study. We thank Marianne Deweirder for the DNA bank management. The DIAB2.NEPHRO.GENE study participating centers are acknowledged here: Poitiers-Diabetology clinic (coordinating center) : F Duengler, R Marechaud, D Gendre, F Torremocha, L Labbe; Poitiers-Nephrology clinic: G Touchard, F Bridoux, A Thierry, R Abou-Ayache, S Belmouaz; Poitiers-Cardiovascular disease prevention center : D Herpin, Ph Sosner, Angers-Diabetology clinic : G Guilloteau, B, Bouhanick; PH Ducluzeau, P. Ritz; Angouleme-Diabetology clinic : A-M Chameau-Lagarde, M. Bonnefoy; Corbeil-Essonnes-Diabetology clinic : JP Riveline, D Dardari, C. Petit ; Limoges-Diabetology clinic : F. Archambeaux-Mouveroux, S. Gallina; Nancy-Diabetology clinic : Ph Bohme, B Guerci, I. Glatz, H. Hallage; Narbonne -Diabetology clinic : N. Vigier, JP Courreges; Niort-Nephrology clinic: A Sechet, M Baron ; Papeete-Diabetology clinic : F. Rachedi ; Paris Bichat-Diabetology clinic : A Ankotche, R Roussel; Rennes-Diabetology clinic : C Faure-Gerard, JY Poirier, D Maugendre; St Mande-HIA Begin-Diabetology clinic : B. Bauduceau, O. Dupuy, H. Mayaudon, J. Margery, R. Poyet; Toulouse-Diabetology clinic: P Gourdy, M Matta, H Hanaire; Tours-CIC, Diabetology clinic and Nephrology clinic : JM Halimi, P Lecomte, M. Francois; Valenciennes-Diabetology clinic : O. Verier-Mine; Valenciennes-Nephrology clinic : P Vanhile. S Ragot & J Guilhot (Clinical Research Center- Poitiers), C Merceron, E Rogeon, F Abriat & the staff of Diabetology Department- Poitiers are acknowledged for their help in data collection and monitoring. S Leroux & G Mauco (both INSERM ERM 324 and Biochemistry-Poitiers) are thanked for biological determinations.
###end p 107
###begin title 108
References
###end title 108
###begin article-title 109
A genome-wide association study identifies novel risk loci for type 2 diabetes.
###end article-title 109
###begin article-title 110
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
###end article-title 110
###begin article-title 111
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
###end article-title 111
###begin article-title 112
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
###end article-title 112
###begin article-title 113
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.
###end article-title 113
###begin article-title 114
Combining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease Prediction.
###end article-title 114
###begin article-title 115
Revisiting the clinical validity of multiplex genetic testing in complex diseases.
###end article-title 115
###begin article-title 116
Identification of Type 2 Diabetes Genes in Mexican Americans Through Genome-wide Association Studies.
###end article-title 116
###begin article-title 117
A Search for Variants Associated with Young-Onset Type 2 Diabetes in American Indians in a 100k Genotyping Array.
###end article-title 117
###begin article-title 118
Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: Evidence for replication from diabetes-related quantitative traits and from independent populations.
###end article-title 118
###begin article-title 119
A 100k Genome-Wide Association Scan for Diabetes and Related Traits in the Framingham Heart Study: Replication and Integration with Other Genome-Wide Datasets.
###end article-title 119
###begin article-title 120
TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis.
###end article-title 120
###begin article-title 121
Variation in the HHEX-IDE gene region predisposes to type 2 diabetes in the prospective, population-based EPIC-Potsdam cohort.
###end article-title 121
###begin article-title 122
Studies of association of variants near the HHEX, CDKN2A/B and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects validation and extension of genome-wide association studies.
###end article-title 122
###begin article-title 123
Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population.
###end article-title 123
###begin article-title 124
Polymorphisms in the IDE-KIF11-HHEX Gene Locus Are Reproducibly Associated with Type 2 Diabetes in a Japanese Population.
###end article-title 124
###begin article-title 125
Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8 and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population.
###end article-title 125
###begin article-title 126
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution.
###end article-title 126
###begin article-title 127
ZnT-8, a pancreatic beta-cell-specific zinc transporter.
###end article-title 127
###begin article-title 128
In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion.
###end article-title 128
###begin article-title 129
###xml 34 39 <span type="species:ncbi:9606">human</span>
Isolation and characterization of human CXCR4-positive pancreatic cells.
###end article-title 129
###begin article-title 130
Genome-wide association studies provide new insights into type 2 diabetes aetiology.
###end article-title 130
###begin article-title 131
p16INK4a induces an age-dependent decline in islet regenerative potential.
###end article-title 131
###begin article-title 132
How many genes underlie the occurrence of common complex diseases in the population?
###end article-title 132
###begin article-title 133
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.
###end article-title 133
###begin article-title 134
Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes.
###end article-title 134
###begin article-title 135
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.
###end article-title 135
###begin article-title 136
###xml 101 107 <span type="species:ncbi:9606">people</span>
Prognostic Value of the Insertion/ Deletion polymorphism of Angiotensin I Converting Enzyme gene for people with type 2 diabetes and raised excretion of urinary albumin : results from the DIABHYCAR study.
###end article-title 136
###begin article-title 137
###xml 193 204 <span type="species:ncbi:9606">participant</span>
A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study-design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXydants.
###end article-title 137
###begin article-title 138
###xml 106 112 <span type="species:ncbi:9606">humans</span>
A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans.
###end article-title 138
###begin article-title 139
Complex haplotypes of the PGC-1alpha gene are associated with carbohydrate metabolism and type 2 diabetes.
###end article-title 139
###begin article-title 140
Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes.
###end article-title 140
###begin article-title 141
ROCR: visualizing classifier performance in R. Bioinformatics
###end article-title 141
###begin p 142
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 142
###begin p 143
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by the French Governmental "Agence Nationale de la Recherche", the European Union (Integrated Project EuroDia LSHM-CT-2006-518153 in the Framework Programme 6 [FP6] of the European-Community, to PF), and the charities "Association Francaise des Diabetiques" and "Programme National de Recherche sur le Diabete".
###end p 143

